Regulatory for value creation.

Ready to turn regulatory strategy into a growth engine? Let’s talk.

HexaReg is a strategic regulatory advisory firm supporting MedTech startups and scaleups.

We believe that regulatory strategy is more than compliance: it’s a lever for growth and valuation.

At HexaReg, we design and support your regulatory roadmap to align with your business and fundraising milestones.

Our approach builds regulatory architectures that accelerate market pathways, manage risk, strengthen your equity story, and increase investor confidence - maximizing value at every stage, from seed to scale.

The HexaReg Value Model.

HexaReg takes inspiration from the hexagon: the simplest shape capable of forming a complete, stable system. Your regulatory strategy should do the same: clear, connected, and focused on value.

Our framework showcases our approach into six interconnected dimensions that help you navigate complexity, structure your regulatory maturity, and create tangible business value across innovation, operations, and M&A.

  • Expert interpretation and strategic positioning of products across regulations borderlines, ensuring optimal classification, reduced regulatory burden, and accelerated market pathways.

  • End-to-end regulatory strategy and tailored to innovation stage, technology type, and market ambition — including global pathway design, risk mapping, and alignment with commercial and clinical plans.

  • Preparation and management of global submissions, technical documentation, and proactive interactions with regulators to secure predictable, timely approvals.

  • Harmonising promotional claims, clinical evidence, and product value narratives to create defensible, competitive, and globally coherent messaging.

  • Shaping regulatory organisations that scale with the business: defining governance, culture, processes, competencies, and cross-functional integration to make regulatory affairs a strategic partner.

  • Supporting both investors and MedTech companies with regulatory due diligence, integration planning, and building investor-ready systems that protect valuation and accelerate post-deal impact.